ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers

類似資料

• Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy
  著者:: Albarakati, Nada, 等
  出版事項: (2014)
• Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
  著者:: Sultana, Rebeka, 等
  出版事項: (2013)
• Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.
  著者:: Rebeka Sultana, 等
  出版事項: (2013-01-01)
• Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts()
  著者:: Abdel-Fatah, Tarek M.A., 等
  出版事項: (2014)
• Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer
  著者:: Abdel-Fatah, Tarek M.A., 等
  出版事項: (2014)